Monday, 14 September 2026European Markets

CARREFOUR, VRANKEN-POMMERY, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(vianews) - carrefour (ca.pa) is among this list of stock assets with the highest dividend rate and return on equity on the consumer defensive sector.

financial asset price forward dividend yield return on equity
carrefour (ca.pa) €15.90 5.3% 6.77%
vranken-pommery (vrap.pa) €15.65 5.1% 2.66%
glanbia plc (gl9.ir) €16.75 2.04% 13.35%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. carrefour (ca.pa)

5.3% forward dividend yield and 6.77% return on equity

carrefour sa operates stores in various formats and channels in france, spain, italy, belgium, poland, romania, brazil, and argentina. the company operates hypermarkets, supermarkets, convenience stores, and cash and carry stores; e-commerce sites; and service stations. its stores offer fresh produce; local products; and non-food products, including electronic and household appliances, textiles, childcare, and seasonal products. the company is also involved in banking, insurance, property development, and franchise activities; the provision of travel agency services; and the rental of shopping malls. carrefour sa was founded in 1959 and is based in massy, france.

earnings per share

as for profitability, carrefour has a trailing twelve months eps of €1.67.

pe ratio

carrefour has a trailing twelve months price to earnings ratio of 9.52. meaning, the purchaser of the share is investing €9.52 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.77%.

yearly top and bottom value

carrefour's stock is valued at €15.90 at 16:30 est, way below its 52-week high of €19.19 and higher than its 52-week low of €14.89.

volatility

carrefour's last week, last month's, and last quarter's current intraday variation average was a negative 0.86%, a negative 0.06%, and a positive 1.16%.

carrefour's highest amplitude of average volatility was 1.76% (last week), 1.46% (last month), and 1.16% (last quarter).

moving average

carrefour's worth is below its 50-day moving average of €16.09 and under its 200-day moving average of €16.81.

more news about carrefour.

2. vranken-pommery (vrap.pa)

5.1% forward dividend yield and 2.66% return on equity

vranken-pommery monopole société anonyme produces and sells wines and champagnes in europe, north america, and the asia pacific. it offers its products under the champagne charles lafitte, champagne demoiselle, champagne pommery, champagne heidsieck & c° monopole, champagne vranken – diamant, champagne germain, sao pedro, rozès, and grifo brands. vranken-pommery monopole société anonyme was founded in 1976 and is headquartered in reims, france.

earnings per share

as for profitability, vranken-pommery has a trailing twelve months eps of €1.15.

pe ratio

vranken-pommery has a trailing twelve months price to earnings ratio of 13.61. meaning, the purchaser of the share is investing €13.61 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.66%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, vranken-pommery's stock is considered to be overbought (>=80).

revenue growth

year-on-year quarterly revenue growth grew by 4.9%, now sitting on 339.97m for the twelve trailing months.

yearly top and bottom value

vranken-pommery's stock is valued at €15.65 at 16:30 est, way under its 52-week high of €19.10 and above its 52-week low of €15.20.

moving average

vranken-pommery's value is below its 50-day moving average of €16.40 and way under its 200-day moving average of €17.59.

more news about vranken-pommery.

3. glanbia plc (gl9.ir)

2.04% forward dividend yield and 13.35% return on equity

glanbia plc operates as a nutrition company worldwide. the company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. it also engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes. in addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, weight management, and bioactive solutions businesses. it operates a portfolio of brands, including optimum nutrition, bsn, isopure, nutramino, slimfast, think!, amazing grass, body & fit, and levlup brands. glanbia plc was founded in 1964 and is headquartered in kilkenny, ireland.

earnings per share

as for profitability, glanbia plc has a trailing twelve months eps of €0.9.

pe ratio

glanbia plc has a trailing twelve months price to earnings ratio of 18.61. meaning, the purchaser of the share is investing €18.61 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.35%.

revenue growth

year-on-year quarterly revenue growth declined by 10.3%, now sitting on 5.84b for the twelve trailing months.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on aug 24, 2023, the estimated forward annual dividend rate is 0.34 and the estimated forward annual dividend yield is 2.04%.

more news about glanbia plc.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,285 source documents archived
Query this data → isubstrate.com